Paper · 42750032

The roles of chromatin remodeling and 3D genome organization in cancers: from mechanistic insights to emerging treatment options.

Luo C and 13 others. Mol Cancer, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. The roles of chromatin remodeling and 3D genome organization in cancers: from mechanistic insights to emerging treatment options. Papers, record 42750032. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42750032

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: The roles of chromatin remodeling and 3D genome organization in cancers: from mechanistic insights to emerging treatment options.; PubMed
Journal: Mol Cancer; PubMed
Year: 2026; PubMed
Publication types: Journal Article, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/42750032/; PubMed
DOI: https://doi.org/10.1186/s12943-026-02763-x; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC13584305/; PubMed
The journal: https://conductscience.org/library/journal-index/101147698; PubMed
Citations, by iCite: 0; iCite
Revised in PubMed: 2026-09-19; PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Luo C	Chuqiao
2	Xia N	Ninglin
3	Hui SY	Shin Yee
4	Wong US	U Sin
5	Tsang JY	Julia Y
6	Hu H	Hong
7	Tsang CM	Chi Man
8	Lo KW	Kwok Wai
9	Sun P	Peng
10	Shao M	Mumin

1 to 10 of 14Source PubMed

See all 14 authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Chromatin Assembly and Disassembly	Major topic
Neoplasms	Major topic
Chromatin	Major topic
Genome, Human	Major topic
Humans
Animals
Chromosomal Proteins, Non-Histone
Cohesins
Gene Expression Regulation, Neoplastic

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Stated by
14110625	Research Grants Council-General Research Fund	PubMed
IDBF25MED10	CUHK Knowledge Transfer Committee-IdeaBooster Fund	PubMed
8509804	United College Endowment Fund Research Grant	PubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References538

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	23,333,522	Synthetic lethality and cancer: cohesin and PARP at the replication fork.	Trends Genet	2013	https://conductscience.org/library/papers/23333522	PubMed
2	30,431,433	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma.	Elife	2018	https://conductscience.org/library/papers/30431433	PubMed
3	25,656,847	SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer.	Cell Res	2015	https://conductscience.org/library/papers/25656847	PubMed
4	11,980,720	WSTF-ISWI chromatin remodeling complex targets heterochromatic replication foci.	EMBO J	2002	https://conductscience.org/library/papers/11980720	PubMed
5	17,320,507	Chromatin modifications and their function.	Cell	2007	https://conductscience.org/library/papers/17320507	PubMed
6	28,954,733	Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers.	Cancer Res	2017	https://conductscience.org/library/papers/28954733	PubMed
7	39,361,741	Relocalizing transcriptional kinases to activate apoptosis.	Science	2024	https://conductscience.org/library/papers/39361741	PubMed
8	31,831,874	ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness.	Cell Death Differ	2020	https://conductscience.org/library/papers/31831874	PubMed
9	40,690,248	Ovarian Cancer: A Review.	JAMA	2025	https://conductscience.org/library/papers/40690248	PubMed
10	38,001,638	ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma.	Cancers (Basel)	2023	https://conductscience.org/library/papers/38001638	PubMed

1 to 10 of 538

See all 538 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42750032

GET https://conductscience.org/api/papers/v1/42750032/references?page=2

API reference For AI assistants